News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
30,751 Results
Type
Article (1077)
Company Profile (1)
Press Release (29673)
Section
Business (7240)
Career Advice (2)
Deals (1254)
Drug Delivery (2)
Drug Development (4710)
Employer Resources (3)
FDA (1790)
Job Trends (733)
News (15214)
Policy (1313)
Tag
Academia (111)
Allergies (1)
Alliances (1583)
Alzheimer's disease (100)
Approvals (1798)
Artificial intelligence (2)
Autoimmune disease (1)
Bankruptcy (6)
Best Places to Work (695)
Biosimilars (7)
Biotechnology (1)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (12)
Cancer (88)
Cardiovascular disease (25)
Career advice (2)
Cell therapy (13)
Cervical cancer (1)
Clinical research (3998)
Collaboration (20)
Compensation (1)
COVID-19 (61)
CRISPR (1)
C-suite (9)
Data (155)
Depression (2)
Diabetes (15)
Diagnostics (247)
Digital health (1)
Drug discovery (4)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (3453)
Employer resources (3)
Events (4342)
Executive appointments (18)
FDA (1899)
Funding (19)
Gene editing (3)
Gene therapy (7)
GLP-1 (12)
Government (114)
Guidances (2)
Healthcare (686)
Huntington's disease (1)
Immunology and inflammation (3)
Indications (2)
Infectious disease (62)
Inflammatory bowel disease (2)
Intellectual property (1)
IPO (497)
Job creations (82)
Job search strategy (2)
Kidney cancer (1)
Layoffs (5)
Legal (233)
Liver cancer (9)
Lung cancer (17)
Lymphoma (1)
Management (2)
Manufacturing (7)
MASH (4)
Medical device (1679)
Medtech (1679)
Mergers & acquisitions (774)
Metabolic disorders (20)
Multiple sclerosis (5)
NASH (2)
Neurodegenerative disease (2)
Neuroscience (120)
NextGen: Class of 2025 (203)
Non-profit (125)
Northern California (128)
Obesity (1)
Opinion (3)
Pain (4)
Pancreatic cancer (2)
Parkinson's disease (2)
Partnered (4)
Patents (14)
Patient recruitment (9)
People (1940)
Phase I (1033)
Phase II (1685)
Phase III (1524)
Pipeline (65)
Postmarket research (213)
Preclinical (413)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (14)
Real estate (137)
Recruiting (1)
Regulatory (1069)
Reports (2)
Research institute (97)
Schizophrenia (8)
Series A (2)
Series B (3)
Sickle cell disease (6)
Southern California (59)
Sponsored (1)
Startups (144)
Supply chain (2)
United States (1113)
Vaccines (6)
Weight loss (1)
Date
Today (4)
Last 7 days (23)
Last 30 days (130)
Last 365 days (1630)
2025 (497)
2024 (1631)
2023 (1850)
2022 (2404)
2021 (2312)
2020 (2166)
2019 (1829)
2018 (1456)
2017 (1582)
2016 (1329)
2015 (1761)
2014 (1467)
2013 (1091)
2012 (1195)
2011 (1287)
2010 (1374)
Location
Africa (12)
Alabama (1)
Arizona (14)
Asia (1846)
Australia (272)
California (244)
Canada (91)
China (19)
Colorado (7)
Connecticut (10)
Delaware (12)
Europe (3345)
Florida (65)
Georgia (14)
Idaho (1)
Illinois (18)
India (2)
Indiana (6)
Japan (10)
Kansas (9)
Maryland (29)
Massachusetts (220)
Michigan (7)
Minnesota (39)
Missouri (7)
Nevada (5)
New Hampshire (2)
New Jersey (140)
New Mexico (2)
New York (80)
North Carolina (94)
Northern California (128)
Ohio (11)
Oklahoma (1)
Oregon (2)
Pennsylvania (58)
Puerto Rico (2)
South America (19)
South Carolina (3)
Southern California (59)
Tennessee (1)
Texas (29)
Utah (6)
Virginia (3)
Washington D.C. (1)
Washington State (11)
West Virginia (1)
30,751 Results for "qt vascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QT Imaging Holdings Announces Shipment of Six QT Breast Acoustic CT Scanners in the First Quarter of 2025
April 2, 2025
·
3 min read
Press Releases
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia
March 6, 2025
·
10 min read
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Business
QT Imaging Announces First Quarter 2024 Financial Results
QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024.
May 10, 2024
·
22 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Press Releases
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
April 22, 2025
·
2 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
Press Releases
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
April 15, 2025
·
2 min read
Biotech Bay
QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell
QT Imaging Holdings, Inc., a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square.
April 22, 2024
·
2 min read
Press Releases
Vasorum Announces FDA Approval of its Celt ACD® PLUS Vascular Closure Device
March 28, 2025
·
3 min read
1 of 3,076
Next
